Founded in 2012 and based in New York, Oscar Health Inc. specializes in offering health insurance services tailored to individuals and families. Leveraging a technology-driven platform, the company provides personalized insurance solutions designed to enhance both the efficiency and quality of healthcare delivery.
As of September 22, 2025 (UTC), OSCR shares closed at $18.50, reflecting a 2.48% decrease from the previous trading session. Over the past 52 weeks, the stock reached a high of $23.09 and a low of $11.20.
According to its latest quarterly report, Oscar Health posted revenue of $286 million for Q2 2025, marking a year-over-year growth of 29%. Despite this, the company reported a net loss of $161 million, underscoring ongoing challenges to its profitability.
Assessments from seven analysts yield an average rating of “Sell” for OSCR, with a 12-month price target of $12.07—indicating a potential downside of approximately 34.76% from the current price.
New investors are advised to conduct thorough due diligence on the company’s fundamentals and overall market conditions before considering an investment in OSCR. It’s also important to monitor Oscar Health’s future profitability and competitive position to support sound investment decisions.